Published: Aug 27, 2024 Written by Amelia Willson Medically Reviewed by Dhruv Patel, BSPS, RPh Published: Aug 27, 2024 Key takeaway: Semaglutide typically begins suppressing appetite within 1-2 weeks of the first dose, with full appetite control building over 4-8 weeks as the dose escalates
Whilst clinical trials have shown modest improvements in cholesterol levels amongst patients using Ozempic, these changes appear largely secondary to weight loss rather than direct lipid-lowering effects
Start your intake Gastrointestinal Side Effects: Comparable Incidence in Clinical Studies Nausea, vomiting, and diarrhea occur in both semaglutide and tirzepatide users
This remains speculative until detailed DXA body composition data from the Phase 3 trials becomes available
During the trial, additional anti-diabetic medication was initiated as an add on to randomized treatment by 15%, 2% and 1% of patients randomized to placebo, semaglutide tablets 7 mg and semaglutide tablets 14 mg, respectively
A: Wegovy may help reduce hunger and food-related thoughts for some individuals, but it does not directly address the emotional reasons people use food to cope with stress, anxiety, loneliness, or other difficult emotions